Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABC

NCT05000736 · clinicaltrials.gov ↗

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Hormone Receptor Positive Advanced Breast Cancer

Interventions

DRUG: palbociclib + aromatase inhibitor
DRUG: fulvestrant

Sponsor

Chinese Academy of Medical Sciences